Telehealth firm Hims plans low-testosterone screening and testosterone therapy

Telehealth company Hims is planning to expand into testosterone screening for men. The offering would include testosterone replacement therapy. The move would mark the company's first venture into prescribing controlled substances. The source article does not provide further details on timing or rollout.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.




Discussion (0)
Log in to join the discussion and vote.
Log in